A Study to Develop Novel Tools for Post-HCT Respiratory Complications


About this study

The purpose of this study is to develop tools to better predict which patients will be at highest risk of lung complications following bone marrow transplantation.



Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients (age ≥ 18 years old).
  • Undergoing evaluation for autologous or allogeneic bone marrow transplant (HCT) at Mayo Clinic Rochester.
  • Scheduled for pre-HCT pulmonary function test by the primary team.

Exclusion Criteria: 

  • Limited mobility requiring use of gait aid or wheelchair.
  • Fall risk.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Hemang Yadav, M.B.B.S.

Open for enrollment

Contact information:

Zhenmei Zhang M.D.


More information


Publications are currently not available

Mayo Clinic Footer